Drug profile · INN
denosumab
CORORA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
denosumab (CORORA) is an FDA-listed pharmaceutical active ingredient. Associated with Amgen. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN denosumab
Brand CORORA
Route SUBCUTANEOUS
Formulation INJECTABLE
ATC code M05BX04
Originator Amgen
Frequently asked questions
What is denosumab?
denosumab (CORORA) is an FDA-listed pharmaceutical active ingredient. Associated with Amgen. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for denosumab?
CORORA is a marketed brand name for denosumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of denosumab?
denosumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.